# CP-690,550 Pharmacokinetics In Healthy Chinese Subjects

> **NCT01101919** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CP-690,550

## Key facts

- **NCT ID:** NCT01101919
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2011-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01101919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01101919, "CP-690,550 Pharmacokinetics In Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01101919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*